Results overview: Found 17 records in 0.02 seconds.
Articles, 14 records found
Research literature, 3 records found
Articles 14 records found  1 - 10next  jump to record:
1.
11 p, 1.2 MB Design of the β3-Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure Trial / Garcia-Lunar, Ines (Hospital Universitario Quirónsalud Madrid, UEM, Madrid, Spain) ; Blanco, Isabel (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain) ; Fernández-Friera, Leticia (HM Hospitales-Centro Integral de Enfermedades Cardiovasculares HM-CIEC, Madrid, Spain) ; Prat-Gonzàlez, Susanna (Institut Clinic Cardiovascular, IDIBAPS, Hospital Clínic, University of Barcelona, Barcelona, Spain) ; Jordà, Paloma (Institut Clinic Cardiovascular, IDIBAPS, Hospital Clínic, University of Barcelona, Barcelona, Spain) ; Sánchez, Javier (Philips Healthcare Iberia, Madrid, Spain) ; Pereda, Daniel (Institut Clinic Cardiovascular, IDIBAPS, Hospital Clínic, University of Barcelona, Barcelona, Spain) ; Pujadas, Sandra (Institut d'Investigació Biomèdica Sant Pau) ; Rivas, Mercedes (Institut d'Investigació Biomèdica Sant Pau) ; Solé-Gonzalez, Eduard (Parc de Salut Mar (Barcelona, Catalunya)) ; Vázquez, Jorge (Cardiology Department, University Hospital Puerta de Hierro, University Autonoma de Madrid, Madrid, Spain) ; Blázquez, Zorba (Cardiology Department, University Hospital 12 de Octubre, Universidad Complutense, Madrid, Spain) ; García-Picart, Juan (Institut d'Investigació Biomèdica Sant Pau) ; Caravaca, Pedro (Cardiology Department, University Hospital 12 de Octubre, Universidad Complutense, Madrid, Spain) ; Escalera, Noemí (Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain) ; Garcia-Pavia, Pablo (University Francisco de Vitoria (UFV), Pozuelo de Alarcon, Spain) ; Delgado, Juan (Cardiology Department, University Hospital 12 de Octubre, Universidad Complutense, Madrid, Spain) ; Segovia-Cubero, Javier (Cardiology Department, University Hospital Puerta de Hierro, University Autonoma de Madrid, Madrid, Spain) ; Fuster, Valentín (Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York) ; Roig, Eulalia (Institut d'Investigació Biomèdica Sant Pau) ; Barberá, Joan Albert (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain) ; Ibanez, Borja (IIS-Fundación Jiménez Díaz University Hospital, Madrid, Spain) ; García-Álvarez, Ana (Institut Clinic Cardiovascular, IDIBAPS, Hospital Clínic, University of Barcelona, Barcelona, Spain) ; Universitat Autònoma de Barcelona
Combined pre-and post-capillary hypertension (CpcPH) is a relatively common complication of heart failure (HF) associated with a poor prognosis. Currently, there is no specific therapy approved for this entity. [...]
2020 - 10.1016/j.jacbts.2020.01.009
JACC: Basic to Translational Science, Vol. 5 (march 2020) , p. 317-327  
2.
18 p, 3.5 MB Beneficial Effect of a Multistrain Synbiotic Prodefen ® Plus on the Systemic and Vascular Alterations Associated with Metabolic Syndrome in Rats : The Role of the Neuronal Nitric Oxide Synthase and Protein Kinase A / Llévenes, Pablo (Universidad Autónoma de Madrid. Department of Physiology. School of Medicine) ; Rodrigues-Díez, Raquel (Research Institute University Hospital la Paz) ; Cros-Brunsó, Laia (Universidad Autónoma de Madrid. Department of Physiology. School of Medicine) ; Prieto, Mᵃ Isabel (Hospital Universitario la Paz. Department of General and Digestive Surgery) ; Casaní, Laura (Institut d'Investigació Biomèdica Sant Pau) ; Balfagón, Gloria (Research Institute University Hospital la Paz) ; Blanco-Rivero, Javier (Research Institute University Hospital la Paz)
A high fat diet (HFD) intake is crucial for the development and progression of metabolic syndrome (MtS). Increasing evidence links gut dysbiosis with the metabolic and vascular alterations associated with MtS. [...]
2020 - 10.3390/nu12010117
Nutrients, Vol. 12 (january 2020)  
3.
12 p, 544.9 KB Association of Apolipoprotein e with Intracerebral Hemorrhage Risk by Race/Ethnicity : A Meta-analysis / Marini, S. (Massachusetts General Hospital) ; Crawford, K. (Massachusetts General Hospital) ; Morotti, A. (Fondazione Mondino IRCCS, Pavia) ; Lee, M.J. (Massachusetts General Hospital) ; Pezzini, A. (Università degli Studi di Brescia) ; Moomaw, C.J. (University of Cincinnati) ; Flaherty, M.L. (University of Cincinnati) ; Montaner, Joan (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Roquer Gonzalez, Jaume (Institut Hospital del Mar d'Investigacions Mèdiques) ; Jimenez Conde, Jordi (Institut Hospital del Mar d'Investigacions Mèdiques) ; Giralt Steinhauer, Eva (Institut Hospital del Mar d'Investigacions Mèdiques) ; Elosua, Roberto (Institut Hospital del Mar d'Investigacions Mèdiques) ; Cuadrado Godia, Elisa (Institut Hospital del Mar d'Investigacions Mèdiques) ; Soriano Tarraga, Carolina (Institut Hospital del Mar d'Investigacions Mèdiques) ; Slowik, A. (Jagiellonian University Medical College, Kraków) ; Jagiella, J.M. (Jagiellonian University Medical College, Kraków) ; Pera, J. (Jagiellonian University Medical College, Kraków) ; Urbanik, A. (Jagiellonian University Medical College, Kraków) ; Pichler, A. (Jagiellonian University Medical College, Kraków) ; Hansen, B.M. (Lund University) ; McCauley, J.L. (John P. Hussman Institute for Human Genomics, Miami) ; Tirschwell, D.L. (University of Washington) ; Selim, M. (Beth Israel Deaconess Medical Center, Boston) ; Brown, D.L. (University of Michigan) ; Silliman, S.L. (University of Florida College of Medicine) ; Worrall, B.B. (University of Virginia Health System) ; Meschia, J.F. (Mayo Clinic, Jacksonville, Florida) ; Kidwell, C.S. (University of Arizona) ; Testai, F.D. (University of Illinois) ; Kittner, S.J. (University of Maryland School of Medicine) ; Schmidt, H. (Medical University of Graz) ; Enzinger, C. (Medical University of Graz) ; Deary, I.J. (University of Edinburgh) ; Rannikmae, K. (University of Edinburgh) ; Samarasekera, N. (University of Edinburgh) ; Salman, R.A.S. (University of Edinburgh) ; Sudlow, C.L. (University of Edinburgh) ; Klijn, C.J.M. (UMC Utrecht Brain Center Rudolf Magnus) ; Van Nieuwenhuizen, K.M. (UMC Utrecht Brain Center Rudolf Magnus) ; Fernandez Cadenas, Israel (Institut d'Investigació Biomèdica Sant Pau) ; Delgado Martínez, María Pilar (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Norrving, B. (Lund University) ; Lindgren, A. (Lund University) ; Goldstein, J.N. (Massachusetts General Hospital) ; Viswanathan, A. (Massachusetts General Hospital) ; Greenberg, S.M. (Massachusetts General Hospital) ; Falcone, G.J. (Yale University) ; Biffi, A. (Massachusetts General Hospital) ; Langefeld, C.D. (Wake Forest University, Winston-Salem, North Carolina) ; Woo, D. (University of Cincinnati College of Medicine) ; Rosand, J. (Massachusetts General Hospital) ; Anderson, C.D. (Massachusetts General Hospital) ; Universitat Autònoma de Barcelona
Importance: Genetic studies of intracerebral hemorrhage (ICH) have focused mainly on white participants, but genetic risk may vary or could be concealed by differing nongenetic coexposures in nonwhite populations. [...]
2019 - 10.1001/jamaneurol.2018.4519
JAMA Neurology, Vol. 76 Núm. 4 (april 2019) , p. 480-491  
4.
10 p, 787.8 KB Population prevalence and control of cardiovascular risk factors : What electronic medical records tell us / Catalán-Ramos, Arantxa (Unitat de Coordinació i Estratègia del Medicament, Direcció Adjunta d'Afers Assistencials, Institut Català de la Salut) ; Verdú, Jose M. (Universitat Autònoma de Barcelona) ; Grau, María (Institut Hospital del Mar d'Investigacions Mèdiques) ; Iglesias-Rodal, Manuel (Institut Català de la Salut, Barcelona) ; del Val García, José L. (Institut Universitari d'Investigació en Atenció Primària (IDIAP Jordi Gol)) ; Consola, Alicia (Aplicaciones en Informática Avanzada (AIA) S.L., Barcelona) ; Comin, Eva (Unitat de Coordinació i Estratègia del Medicament, Direcció Adjunta d'Afers Assistencials, Institut Català de la Salut)
To analyze the prevalence, control, and management of hypertension, hypercholesterolemia, and diabetes mellitus type 2 (DM2). Cross-sectional analysis of all individuals attended in the Catalan primary care centers between 2006 and 2009. [...]
2013 - 10.1016/j.aprim.2013.06.004
Atencion Primaria, Vol. 46 (december 2013) , p. 15-24  
5.
10 p, 660.3 KB Impact of implementing electronic clinical practice guidelines for the diagnosis, control and treatment of cardiovascular risk factors : A pre-post controlled study / Comin, Eva (Institut Català de la Salut, Barcelona) ; Catalan-Ramos, Arantxa (Agència de Qualitat i Avaluació Sanitàries de Catalunya, Barcelona) ; Iglesias-Rodal, Manuel (Institut Català de la Salut, Barcelona) ; Grau, Maria (Institut Hospital del Mar d'Investigacions Mèdiques) ; del Val, Jose Luis (Institut Universitari d'Investigació en Atenció Primària (IDIAP Jordi Gol)) ; Consola, Alicia (Aplicaciones en Informática Avanzada (AIA)) ; Amado, Ester (Institut Català de la Salut, Barcelona) ; Pons, Angels (Institut Català de la Salut, Barcelona) ; Mata-Cases, Manel (Institut Català de la Salut, Barcelona) ; Franzi, Alicia (Institut Català de la Salut, Barcelona) ; Frigola, Eva (Universitat Autònoma de Barcelona. Institut Universitari de Qualitat Assistencial i Seguretat Clínica Avedis Donabedian) ; Cos, Xavier (Institut Català de la Salut, Barcelona) ; Davins, Josep (Subdirecció General de Serveis Sanitaris, Departament de Salut) ; Verdu-Rotellar, Jose M. (Universitat Autònoma de Barcelona)
To evaluate the impact of computerized clinical practice guidelines on the management, diagnosis, treatment, control, and follow-up of the main cardiovascular risk factors: hypertension, hypercholesterolaemia, and type 2 diabetes mellitus. [...]
2017 - 10.1016/j.aprim.2016.11.007
Atencion Primaria, Vol. 49 (march 2017) , p. 389-398  
6.
10 p, 849.1 KB Proximal pulmonary arterial wall disease in patients with persistent pulmonary hypertension after successful left-sided valve replacement according to the hemodynamic phenotype / Domingo, Enric (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Grignola, Juan C. (Universidad de la República. Hospital de Clínicas (Montevideo, Uruguay)) ; Trujillo, Pedro (Universidad de la República. Hospital de Clínicas (Montevideo, Uruguay)) ; Aguilar, Rio (Hospital de la Princesa (Madrid)) ; Roman, Antonio (Hospital Universitari Vall d'Hebron)
Regression of pulmonary hypertension (PH) is often incomplete after successful left-sided valve replacement (LSVR). Proximal pulmonary arterial (PPA) wall disease can be involved in patients with persistent-PH after LSVR, affecting the right ventricular to pulmonary arterial (RV-PA) coupling. [...]
2018 - 10.1177/2045894018816972
Pulmonary Circulation, Vol. 9 (december 2018)  
7.
15 p, 1.0 MB COSMIC project : consensus on the objectives of the metabolic syndrome in clinic / Pedro-Botet, Juan (Universitat Autònoma de Barcelona. Departament de Medicina) ; Ascaso, Juan F (INCLIVA Research Institute, Diabetes and Metabolic Diseases Ciber, Valencia) ; Barrios, Vivencio (Departamento de Medicina, Universidad Católica de Murcia (UCAM), Murcia) ; De la Sierra, Alejandro (Hospital Mutua de Terrassa, Universidad de Barcelona) ; Escalada, Javier (CIBEROBN , Instituto de Salud Carlos III) ; Millán, Jesús (Lipid Unit, Department of Internal Medicine, Hospital Universitario General Gregorio Marañón, Universidad Complutense) ; Mostaza, Jose M (Lipid and Arteriosclerosis Unit, Internal Medicine Service, Hospital Carlos III, Madrid, Spain) ; Pérez-Martínez, Pablo (Lipid and Arteriosclerosis Unit, Hospital Universitario Reina Sofía) ; Pintó, Xavier (Hospital Universitario de Bellvitge, Universidad de Barcelona, Barcelona, Spain) ; Salas-Salvadó, Jordi (Hospital Universitari Sant Joan de Reus, Department of Biochemistry and Biotechnology, Universitat Rovira i Virgili) ; Valdivielso, Pedro (Hospital Universitario Virgen de la Victoria, Málaga Biomedicine Institute (IBIMA), Universidad de Málaga, Málaga, Spain)
Metabolic syndrome (MetS), a disorder with a high and growing prevalence, is a recognized risk factor for cardiovascular disease (CVD) and type 2 diabetes. It is a constellation of clinical and metabolic risk factors that include abdominal obesity, dyslipidemia, glucose intolerance, and hypertension. [...]
2018 - 10.2147/DMSO.S165740
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol. 11 (october 2018) , p. 683-697  
8.
10 p, 568.4 KB High sensitivity and negative predictive value of the DETECT algorithm for an early diagnosis of pulmonary arterial hypertension in systemic sclerosis : application in a single center / Guillén-Del Castillo, Alfredo (Hospital Universitari Vall d'Hebron) ; Callejas-Moraga, Eduardo L. (Hospital Universitari Vall d'Hebron) ; García, Gabriela (Hospital Universitari Vall d'Hebron) ; Rodríguez-Palomares, José F. (Hospital Universitari Vall d'Hebron) ; Román, Antonio (Román Broto) (Hospital Universitari Vall d'Hebron) ; Berastegui, Cristina (Hospital Universitari Vall d'Hebron) ; López-Meseguer, Manuel ; Domingo, Enric (Hospital Universitari Vall d'Hebron) ; Fonollosa-Plá, Vicente (Hospital Universitari Vall d'Hebron) ; Simeón-Aznar, Carmen Pilar (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Pulmonary arterial hypertension (PAH) is one of the most relevant causes of death in systemic sclerosis. The aims of this study were to analyse the recently published DETECT algorithm comparing it with European Society of Cardiology/European Respiratory Society (ESC/ERS) 2009 guidelines: as screening of PAH; (2) identifying median pulmonary arterial pressure (mPAP) ≥21 mmHg; and (3) determining any group of pulmonary hypertension (PH). [...]
2017 - 10.1186/s13075-017-1327-8
Arthritis research & therapy, Vol. 19 (june 2017)  
9.
4 p, 1.3 MB Gastric Dilatation and Abdominal Compartment Syndrome in a Child with Prader-Willi Syndrome / Blat, (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Busquets, Elisenda (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Gili, Teresa (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Caixàs, Assumpta (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Gabau, Elisabeth (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Corripio, Raquel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Universitat Autònoma de Barcelona
Rare disease Prader-Willi syndrome (PWS) is a genetic disorder characterized by initial muscular hypotonia and feeding difficulties, and later an insatiable appetite, hyperphagia and obesity along with mild to moderate intellectual impairment. [...]
2017 - 10.12659/AJCR.903608
The American Journal of Case Reports, Vol. 18 (june 2017) , p. 637-640  
10.
9 p, 966.9 KB Pulmonary arterial wall disease in COPD and interstitial lung diseases candidates for lung transplantation / Domingo, Enric (Hospital Universitari Vall d'Hebron) ; Grignola, Juan C. (Universidad de la República, Montevideo, Uruguay) ; Aguilar, Rio (Hospital Universitario de la Princesa, Madrid) ; Messeguer, Manuel López (Hospital Universitari Vall d'Hebron) ; Roman, Antonio (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Pulmonary hypertension (PH) associated with lung disease has the worst prognosis of all types of PH. Pulmonary arterial vasculopathy is an early event in the natural history of chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD). [...]
2017 - 10.1186/s12931-017-0568-z
Respiratory Research, Vol. 18 (may 2017)  

Articles : 14 records found   1 - 10next  jump to record:
Research literature 3 records found  
1.
166 p, 1.0 MB Efectivitat dels Inhibidors de l'Eix Renina-Angiotensina en pacients amb diabetis mellitus tipus 2 i hipertensió arterial a CATalunya. Estudi de cohorts IERACAT / Morros, Rosa ; Torrent Farnell, Josep, dir. (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Badia Llach, Xavier, dir. (Consorci Sanitari Barcelona) ; Antonijoan Arbós, Rosa Ma., (Rosa María), dir. (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia
Objectius: Avaluar la morbiditat i la mortalitat dels pacients diabètics hipertensos tractats amb un inhibidor de l'enzim convertidor d'angiotensina (IECA) i / o un antagonista del receptor d'angiotensina II (ARAII) a Catalunya. [...]
[Barcelona] : Universitat Autònoma de Barcelona, 2017.  
2.
1 p, 367.7 KB Hibiscus sabdariffa : a potential strategy to decrease aging-induced cardiovascular risk? / Farré Alins, Víctor ; Jiménez Altayó, Francesc, dir. (Universitat Autònoma de Barcelona.Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2015
Grau en Ciències Biomèdiques [832]  
3.
61 p, 1.8 MB Estudio del papel fisiopatológico de la resistencia a la insulina en la cirrosis / Erice Muñoz, Eva ; Solà Lamoglia, Ricard, dir. ; Garcia-Pagan, Juan Carlos, dir. ; Bosch Genover, J., dir. ; Universitat Autònoma de Barcelona. Departament de Medicina
Los factores de riesgo cardiovascular, como la hipertensión arterial, la diabetes o la dislipemia, están íntimamente relacionados con el fenómeno de resistencia a la insulina, mecanismo fisiopatológico responsable de la aparición de disfunción endotelial y del desarrollo de complicaciones cardiovasculares. [...]
Cardiovascular factors, such as arterial hypertension, dyslipemia or diabetes are associated with insulin resistance, which is responsible for development of endothelial dysfunction and consequently cardiovascular diseases. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2015  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.